A Study of CM310 in Subjects With Moderate to Severe Asthma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study of CM310 in Subjects With Moderate to Severe Asthma — Stella

Home/Moderate to Severe Asthma/

View on ClinicalTrials.gov

Recruiting

Back to Moderate to Severe Asthma trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

China

China-Japan Friendship Hospital, Beijing, Beijin

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Enrollment target

~600 participants

Started

April 2023

Primary completion

May 2032

Age range

12 Years – 75 Years

Last updated December 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.